Search Results 2031-2040 of 14834 for anti-TNF drugs

  1. Aminolevulinic Acid (Topical Route) Precautions - Mayo Clinic

    For Levulan® Kerastick® topical solution: Avoid exposure to light if you experience stinging or burning on the treated areas before blue light treatment. During ...

  2. Publications - Tyler S. Oesterle, M.D., M.P.H. - Mayo Clinic

    Bormann NL, Weber AN, Oesterle TS, Miskle B, Lynch AC, Arndt S. State inequities: Gaps in planned treatment for criminal legal referrals with opioid use ...

  3. Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis - Mayo Clinic

    ... therapy, anti-inflammatory medications/acetaminophen or injection therapy (e.g., cortisone) 8. Fully understanding of the requirements of the study and ...

  4. Dinutuximab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Unituxin. Descriptions. Dinutuximab injection is used in ...

  5. Science Saturday: Advancing cell-based regenerative therapy for heart failure - Mayo Clinic News Network

    "The safety and efficacy of stem cell therapy have been documented in advanced clinical trials, but the method of cell manufacturing had remained cost- ...

  6. A Study Comparing the Safety of Tofacitinib versus Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... By condition, treatment or drug name. Search tips. A Study Comparing the ...

  7. Nontuberculosis Mycobacterial Infections Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium complex (MAC) disease, ...

  8. Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA - Mayo Clinic

    Clinical Trials · Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA · More about research at Mayo ...

  9. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...

  10. A Trial to Evaluate the Safety of GEN1046 in Patients with Malignant Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Toxicities from previous anti-cancer therapies that have not ...